Li Li

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Intestinal epithelial SETD2 maintains gut microbial homeostasis to attenuate colitis.

Intestinal epithelial SETD2 maintains gut microbial homeostasis to attenuate colitis.

Journal: Clinical and translational medicine
Published: March 16, 2026

NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.

NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.

Journal: Cell death & disease
Published: July 19, 2025

NSD2 promotes cell durotaxis and drives the transition from polycystic kidney disease to tubulocystic renal cell carcinoma through integrin/FAK/AKT signaling.

NSD2 promotes cell durotaxis and drives the transition from polycystic kidney disease to tubulocystic renal cell carcinoma through integrin/FAK/AKT signaling.

Journal: Oncogene
Published: February 07, 2025

Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease.

Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease.

Journal: Theranostics
Published: October 26, 2024

Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.

Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.

Journal: Clinical and translational medicine
Published: August 09, 2024

Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.

Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.

Journal: Clinical and translational medicine
Published: June 15, 2023

SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer.

SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer.

Journal: Nature communications
Published: February 19, 2023

Setd2 supports GATA3+ST2+ thymic-derived Treg cells and suppresses intestinal inflammation.

Setd2 supports GATA3+ST2+ thymic-derived Treg cells and suppresses intestinal inflammation.

Journal: Nature communications
Published: November 27, 2021

The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis.

The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis.

Journal: Redox biology
Published: December 21, 2020

Loss of Setd2 associates with aberrant microRNA expression and contributes to inflammatory bowel disease progression in mice.

Loss of Setd2 associates with aberrant microRNA expression and contributes to inflammatory bowel disease progression in mice.

Journal: Genomics
Published: December 12, 2020

Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.

Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.

Journal: Cancer research
Published: November 26, 2020

BRG1 attenuates colonic inflammation and tumorigenesis through autophagy-dependent oxidative stress sequestration.

BRG1 attenuates colonic inflammation and tumorigenesis through autophagy-dependent oxidative stress sequestration.

Journal: Nature communications
Published: November 22, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026